Cipla incorporates JV company in USA
Cipla completes transfer of Generics Business Undertaking
Cipla completes transfer of Generics Business Undertaking
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Eugia Pharma Specialities restarts production at terminally sterilized product lines
BHL will undertake the development and supply of these molecules
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
Subscribe To Our Newsletter & Stay Updated